NVIDIA closed Tuesday at $227.21, essentially where it was a week ago, and the story this week is less about what the stock has done than about the growing spread between where it trades and where most analysts think it belongs.
The Street remains broadly bullish, but the range of conviction has widened considerably. Rosenblatt reiterated its Buy with a $390 target on September 29. Bernstein holds the highest target at $400, raised from $315 after the August earnings beat. JP Morgan lifted its target to $320 from $280 on the same day. Against a current price of $227.21, those targets imply upside of 40% to 76%, a gap that is either an opportunity or a sign that targets were set in a different sentiment environment. Piper Sandler initiated with an Overweight and a $300 target on September 10, sitting at the lower end of a range that now spans $300 to $400 across the visible analyst universe. The consensus direction is unambiguously positive, with 10 Outperform ratings recorded, but the $100 spread between the floor and ceiling of published targets tells you the Street is not unified on how much of the AI story is already priced. At 16.2x trailing earnings and 11.3x book, the valuation multiples have drifted lower over the past 30 days, with the PE down roughly 0.4 turns and price-to-book off 0.6 turns, a modest compression that suggests the stock has not kept pace with the post-earnings target upgrades.
The positioning picture is calm in a way that stands in contrast to the headline noise surrounding the company. Short interest is just 1.2% of the free float, little changed over the past week, and availability in the borrow market is essentially unlimited. There is no meaningful short pressure here. Options tell a similarly relaxed story. The put/call ratio is 0.88, below its 20-day average of 0.93 and about 0.7 standard deviations on the call-leaning side. That ratio touched 1.10 at the September 15 peak, a reading flagged in the previous note as the 52-week high, and has since normalised completely. Cost to borrow has ticked up 41% over the past week, but at 0.25% it remains one of the cheapest borrows in the semiconductor universe. The ORTEX short score sits at 29.9, near the low end of any meaningful scale, confirming that the borrow market reflects no structural bear thesis.
The bull case, as laid out by analysts covering the name, rests on platform depth. More than 100 organisations are working within NVIDIA's AI ecosystem. The planned acquisition of Hugging Face, valued at roughly $12.9 billion, extends the company's reach into model development and deployment while preserving a hardware-neutral front end that could sustain GPU demand even without exclusive compute arrangements. Bernstein's target of $400 implicitly prices in the Blackwell and Rubin GPU cycles exceeding the company's own $1 trillion data centre target. The bear case is less about the immediate business and more about what could break the narrative: hyperscaler capex discipline, custom ASIC competition from the likes of Google and Amazon, and the structural question raised by the DeepSeek-Huawei partnership over whether NVIDIA's software moat is as durable as the hardware moat. The EV/EBITDA multiple, which has compressed sharply over the past 30 days, down more than 6 turns, suggests that some of that multiple risk is already being acknowledged in price.
The insider register deserves a brief note of continuity. The previous article on this stock, published earlier today, covered the Mark Stevens $298 million discretionary sale in detail. That transaction remains the most significant insider event in the recent window. The subsequent sales by CFO Colette Kress and General Counsel Timothy Teter were executed under 10b5-1 plans and carry little incremental read-through. The net 90-day insider position is negative $967 million in value terms, but that figure is dominated by the Stevens trade. Nothing has changed in the data that would alter the read from earlier today.
The factor picture is broadly supportive. EPS momentum ranks in the 81st percentile over 30 days and the 76th over 90 days. The analyst recommendation differential ranks in the 92nd percentile. The short score rank, at 84, reflects how little pressure the lending market is putting on this stock. The one area of softness is forward earnings growth, where the 12-month forward year-on-year EPS increase ranks in just the 27th percentile, a reminder that the current quarter requires the company to grow against its own very demanding prior-year base.
With the next earnings event on November 25, the next six to eight weeks narrow to a single question: whether Blackwell demand visibility holds as hyperscaler budgets come under quarterly review. The spread between the $227 stock price and a $300 to $400 analyst target range will either compress on continued data centre order flow, or widen further if the macro backdrop tightens capex sentiment before the print.
See the live data behind this article on ORTEX.
Open NVDA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
